Britni Turano
Psychiatric/Mental Health · Riverside, RINPI 1073286019
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,027 and has fallen 71.6% since, to $576 in 2025. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$791
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$518
- Vanda Pharmaceuticals Inc.$502
- Alkermes, Inc.$493
- Otsuka America Pharmaceutical, Inc.$339
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,32999%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,056 |
| Neurocrine Biosciences, Inc. | 18 | $791 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $518 |
| Vanda Pharmaceuticals Inc. | 15 | $502 |
| Alkermes, Inc. | 26 | $493 |
| Otsuka America Pharmaceutical, Inc. | 11 | $339 |
| Lundbeck LLC | 14 | $327 |
| Ironshore Pharmaceuticals Inc. | 14 | $289 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $273 |
| Axsome Therapeutics, Inc. | 9 | $214 |
| Corium, LLC | 6 | $150 |
| Teva Pharmaceuticals USA, Inc. | 12 | $138 |
| Sunovion Pharmaceuticals Inc. | 7 | $126 |
| Bausch Health US, LLC | 3 | $56 |
| Johnson & Johnson | 2 | $47 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,375 in reported general payments places this provider in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Other psychiatric/mental health in Riverside
- Samuel KaufmanRiverside$19K
- Katelyn AgnewRiverside$3K
- Elizabeth RaposaRiverside$1K
- Samantha Shawn MarshBradford$639K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Eniayo EgberongbeCranston$12K
- Deborah HorvitzWarwick$10K
- Donna McDonaldProvidence$9K
- Timothy PepinNorth Smithfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.